Dr Reddys Laboratories (RDY) Non-Current Assets (2017 - 2026)

Dr Reddys Laboratories has reported Non-Current Assets over the past 10 years, most recently at $3.0 billion for Q1 2026.

  • For Q1 2026, Non-Current Assets rose 8.18% year-over-year to $3.0 billion; the TTM value through Mar 2026 reached $3.0 billion, up 8.18%, while the annual FY2026 figure was $3.0 billion, 6.69% up from the prior year.
  • Non-Current Assets for Q1 2026 was $3.0 billion at Dr Reddys Laboratories, up from $2.8 billion in the prior quarter.
  • Over five years, Non-Current Assets peaked at $3.0 billion in Q1 2026 and troughed at $32.7 million in Q1 2022.
  • A 5-year average of $1.5 billion and a median of $1.7 billion in 2024 define the central range for Non-Current Assets.
  • Biggest five-year swings in Non-Current Assets: soared 3994.17% in 2024 and later increased 8.18% in 2026.
  • Year by year, Non-Current Assets stood at $32.7 million in 2022, then increased by 25.38% to $41.0 million in 2023, then soared by 3994.17% to $1.7 billion in 2024, then skyrocketed by 67.01% to $2.8 billion in 2025, then grew by 8.18% to $3.0 billion in 2026.
  • Business Quant data shows Non-Current Assets for RDY at $3.0 billion in Q1 2026, $2.8 billion in Q1 2025, and $1.7 billion in Q1 2024.